Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Ovarian hemangioma is a rare, benign tumor that can be treated effectively with surgical removal.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

After tumor removal, the woman regained normal hormone levels, menstruated, and had a healthy baby.

Excessive body hair in women with PCOS can lower self-esteem and cause depression and anxiety.

Accurate diagnosis and treatment of hyperandrogenism in women require comprehensive evaluation of symptoms and hormone levels.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

A 20-year-old woman was found to have a rare ovarian tumor causing symptoms like acne and a low-pitched voice, which disappeared after the tumor was removed.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Hirsutism in Afghan women varies by community, influenced by awareness, education, and socio-economic status.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Women with PCOS have higher risks of heart disease, type 2 diabetes, and endometrial cancer.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.